Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.11.2018 | Case report

Antipsoriatics

Hepatocellular carcinoma, hepatitis B reactivation and hepatitis C reactivation: 10 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Chiu H-Y, et al. Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study. Acta Dermato-Venereologica 98: 829-834, No. 9, Jan 2018. Available from: URL: http://doi.org/10.2340/00015555-2989 - TaiwanCrossRef Chiu H-Y, et al. Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study. Acta Dermato-Venereologica 98: 829-834, No. 9, Jan 2018. Available from: URL: http://​doi.​org/​10.​2340/​00015555-2989 - TaiwanCrossRef
Metadaten
Titel
Antipsoriatics
Hepatocellular carcinoma, hepatitis B reactivation and hepatitis C reactivation: 10 case reports
Publikationsdatum
01.11.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-54316-6

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Rituximab

Case report

Osimertinib

Case report

Voriconazole

Case report

Immune globulin

Case report

Melatonin